MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-08-2023
Tabula Rasa HealthCare Current Ratio 2011-2026 | TRHC
Annual Current Ratio Tabula Rasa HealthCare
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.871 | 1.13 | 1.49 | 2.36 | 0.836 | 1.21 | 1.42 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.36 | 0.836 | 1.33 |
Quarterly Current Ratio Tabula Rasa HealthCare
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.82 | 0.83 | 0.87 | 0.93 | - | 1.08 | 1.13 | 1.16 | 1.18 | 1.2 | 1.49 | 1.49 | 1.49 | 1.49 | 1.6 | 1.6 | 1.6 | 1.6 | 2.05 | 2.05 | 2.05 | 2.05 | 2.94 | 2.94 | 2.94 | 2.94 | 4.37 | 4.37 | 4.37 | 4.37 | 0.96 | 0.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.37 | 0.82 | 1.97 |
Current Ratio of other stocks in the Health information services industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
5.62 | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
1.98 | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
1.75 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
1.82 | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
1.49 | - | - | $ 9.03 B | USA |
 |
Castlight Health, Inc.
CSLT
|
2.47 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
4.88 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
4.24 | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
1.9 | $ 2.61 | 3.16 % | $ 245 M | USA |
 |
10x Genomics
TXG
|
4.31 | $ 25.02 | 6.09 % | $ 2.93 B | USA |
 |
GoodRx Holdings
GDRX
|
2.09 | $ 2.26 | 4.88 % | $ 872 M | USA |
 |
SCWorx Corp.
WORX
|
10.6 | - | - | $ 7.71 M | USA |
 |
Akerna Corp.
KERN
|
2.15 | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.38 | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
3.12 | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
3.03 | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
2.92 | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
3.23 | $ 6.16 | 3.88 % | $ 105 M | USA |
 |
Health Catalyst
HCAT
|
1.96 | $ 1.11 | 4.25 % | $ 77.6 M | USA |
 |
HealthEquity
HQY
|
2.66 | $ 80.55 | 0.79 % | $ 6.94 B | USA |
 |
Premier
PINC
|
1.98 | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
2.01 | $ 11.94 | 4.28 % | $ 877 M | USA |
 |
Phreesia
PHR
|
2.03 | $ 8.68 | 1.34 % | $ 519 M | USA |
 |
R1 RCM
RCM
|
1.31 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
1.94 | $ 5.33 | 2.01 % | $ 939 M | USA |
 |
Signify Health
SGFY
|
1.89 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
1.53 | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
0.414 | - | -46.64 % | $ 10.4 M | USA |
 |
American Well Corporation
AMWL
|
4.26 | $ 5.36 | -3.42 % | $ 86 M | USA |
 |
HealthStream
HSTM
|
2.14 | $ 20.63 | 1.28 % | $ 627 M | USA |
 |
Omnicell
OMCL
|
2.42 | $ 35.8 | 2.26 % | $ 1.65 B | USA |
 |
Progyny
PGNY
|
3.28 | $ 17.07 | 0.53 % | $ 1.46 B | USA |
 |
So-Young International
SY
|
3.52 | $ 2.72 | 0.93 % | $ 216 M |  China |
 |
Veeva Systems
VEEV
|
5.09 | $ 159.06 | 0.38 % | $ 26 B | USA |
 |
Zhongchao
ZCMD
|
15.6 | $ 1.96 | -2.49 % | $ 6.7 M | China |